AMD Archives

Scientists test potential drug developed in Australia

July 31, 2020
Michelle Hauschild

A new chemical compound could become a future tool against retinal vascular disease. The finding is the result of a pre-clinical study, led by UNSW researchers.

Ita Buttrose with text saying: Ita's plea

Ita’s coronavirus plea

July 10, 2020
Michelle Hauschild

Australian icon Ita Buttrose has issued a passionate plea to senior Australians in a bid to avoid thousands of people going unnecessarily blind during the COVID-19 pandemic.

image of test tubes in research laboratory

Pre-clinical trial on potential AMD drug

July 3, 2020
Michelle Hauschild

A new chemical compound could become a future tool against retinal vascular disease, a pre-clinical study has shown.

Ita’s plea to older Australians

May 7, 2020
Michelle Hauschild

Australian icon Ita Buttrose has issued a passionate plea to senior Australians during the COVID-19 pandemic.

Life in lockdown: Our volunteers

May 5, 2020
Michelle Hauschild

COVID-19 has meant that our valued volunteers have been working remotely. Their time in isolation has been busy and meaningful.

Diet and risk

April 12, 2020
Michelle Hauschild

MDFA Ambassador Jean Kittson lives with a 50 per cent chance of developing AMD, so she makes sure she eats for eye health.

Risk of increased blindness in COVID confusion

April 3, 2020
Michelle Hauschild

Australia is facing a massive increase in the number of people who could unnecessarily lose their sight due to treatment cancellations caused by fear and confusion around COVID-19.

Vision Voice Autumn 2020 out now

March 31, 2020
Michelle Hauschild

The Autumn 2020 edition of Vision Voice includes an update on the Medicare Benefits Schedule review, plus we farewell our Patron Ita Buttrose.

COVID-19 announcement

March 27, 2020
Michelle Hauschild

With the spread COVID-19, there’s a lot of new health information to understand. What’s the impact on the macular disease community?

Disease Type: AMD

Ita’s coronavirus plea

Pre-clinical trial on potential AMD drug

Ita’s plea to older Australians

Life in lockdown: Our volunteers

Risk of increased blindness in COVID confusion

Vision Voice Autumn 2020 out now

COVID-19 announcement

Follow us

Newsletter sign-up

Thank you.
Your contact form has been successfully submitted.

Unfortunately there are no matches for your search.

Please try another search term.

Thank you for your order!

Your pack will be sent in the next two business days.

Your expression of interest in our research grants program has been submitted.

We will be in touch at the next stage of the process.

Thank you for referring to MDFA for non-clinical support and macular disease information. We will be in contact in 2-3 business days.

Thank you for referring to MDFA for non-clinical support and macular disease information. We will be in contact in 2-3 business days.

Thank you for subscribing to MDFA’s newsletter/s.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about MDFA’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters:

Thank you for registering for this event.

Let people know you're attending:

The is for health professionals only. Please enter your organisation and practitioner type to subscribe. If you are not a health professional, please untick this newsletter to continue.

Disease Type: AMD

Follow us

Newsletter sign-up

Thank you.Your contact form has been successfully submitted.

Unfortunately there are no matches for your search.

Please try another search term.

Thank you for your order!

Your pack will be sent in the next two business days.

Your expression of interest in our research grants program has been submitted.

We will be in touch at the next stage of the process.

Thank you for referring to MDFA for non-clinical support and macular disease information. We will be in contact in 2-3 business days.

Thank you for referring to MDFA for non-clinical support and macular disease information. We will be in contact in 2-3 business days.

Thank you for subscribing to MDFA’s newsletter/s.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.Tell people about MDFA’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.Tell people about Macular Disease Foundation’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.Tell people about Macular Disease Foundation’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.Tell people about Macular Disease Foundation’s newsletters:

Thank you for registering for this event.

Let people know you're attending:

The is for health professionals only. Please enter your organisation and practitioner type to subscribe. If you are not a health professional, please untick this newsletter to continue.

Thank you.
Your contact form has been successfully submitted.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about MDFA’s newsletters:

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters:

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters:

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters: